Brief: Hamlet Pharma Initiates A GLP Study

HAMLET Pharma AB

19/12/2019 07:34

Dec 19 (Reuters) - Hamlet Pharma AB  HAMLET.TE :
    * HAMLET PHARMA INITIATES A GLP STUDY TO EVALUATE IF
INTRACEREBRAL
INFUSION OF THE DRUG CANDIDATE ALPHA1H HAS ANY TOXIC EFFECTS
    * TO ENGAGE IN A CLINICAL TRIAL OF ALPHA1H FOR TREATMENT OF
BRAIN
TUMORS.

Source text for Eikon:  ID:nWkr8Qj5pK 
Further company coverage:  HAMLET.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))